Search

Integra LifeSciences Holdings Corp

Cerrado

SectorSanidad

18.94

Resumen

Variación precio

24h

Actual

Mínimo

18.52

Máximo

19.27

Métricas clave

By Trading Economics

Ingresos

-2.9M

-4.6M

Ventas

-43M

392M

BPA

0.54

Margen de beneficios

-1.178

Empleados

4,427

EBITDA

-3.1M

63M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+9.42% upside

Dividendos

By Acuity

Próximas Ganancias

29 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

632M

1.5B

Apertura anterior

18.94

Cierre anterior

18.94

Noticias sobre sentimiento de mercado

By Acuity

24%

76%

45 / 340 Clasificación en Healthcare

Integra LifeSciences Holdings Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 jul 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Comparación entre iguales

Cambio de precio

Integra LifeSciences Holdings Corp previsión

Precio Objetivo

By TipRanks

9.42% repunte

Estimación a 12 Meses

Media 20.67 USD  9.42%

Máximo 27 USD

Mínimo 15 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Integra LifeSciences Holdings Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

8 ratings

2

Comprar

5

Mantener

1

Vender

Sentimiento

By Acuity

45 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.